Literature DB >> 24082407

Correlation of tumor-infiltrating lymphocytes to histopathological features and molecular phenotypes in canine mammary carcinoma: A morphologic and immunohistochemical morphometric study.

Jong-Hyuk Kim1, Seung-Ki Chon, Keum-Soon Im, Na-Hyun Kim, Jung-Hyang Sur.   

Abstract

Abundant lymphocyte infiltration is frequently found in canine malignant mammary tumors, but the pathological features and immunophenotypes associated with the infiltration remain to be elucidated. The aim of the present study was to evaluate the relationship between lymphocyte infiltration, histopathological features, and molecular phenotype in canine mammary carcinoma (MC). The study was done with archived formalin-fixed, paraffin-embedded samples (n = 47) by histologic and immunohistochemical methods. The degree of lymphocyte infiltration was evaluated by morphologic analysis, and the T- and B-cell populations as well as the T/B-cell ratio were evaluated by morphometric analysis; results were compared with the histologic features and molecular phenotypes. The degree of lymphocyte infiltration was significantly higher in MCs with lymphatic invasion than in those without lymphatic invasion (P < 0.0001) and in tumors of high histologic grade compared with those of lower histologic grade (P = 0.045). Morphometric analysis showed a larger amount of T-cells and B-cells in MCs with a higher histologic grade and lymphatic invasion, but the T/B ratio did not change. Lymphocyte infiltration was not associated with histologic type or molecular phenotype, as assessed from the immunohistochemical expression of epidermal growth factor receptor 2, estrogen receptor, cytokeratin 14, and p63. Since intense lymphocyte infiltration was associated with aggressive histologic features, lymphocytes may be important for tumor aggressiveness and greater malignant behavior in the tumor microenvironment.

Entities:  

Mesh:

Year:  2013        PMID: 24082407      PMCID: PMC3605931     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  31 in total

Review 1.  Humoral immunity, inflammation and cancer.

Authors:  Ting-Ting Tan; Lisa M Coussens
Journal:  Curr Opin Immunol       Date:  2007-02-02       Impact factor: 7.486

2.  Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method.

Authors:  M Karayannopoulou; E Kaldrymidou; T C Constantinidis; A Dessiris
Journal:  J Comp Pathol       Date:  2005-10-03       Impact factor: 1.311

3.  Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.

Authors:  Mi-Jung Kim; Jae Y Ro; Sei-Hyun Ahn; Hak Hee Kim; Sung-Bae Kim; Gyungyub Gong
Journal:  Hum Pathol       Date:  2006-07-18       Impact factor: 3.466

4.  p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas.

Authors:  Irina Matos; Rozany Dufloth; Marcelo Alvarenga; Luiz Carlos Zeferino; Fernando Schmitt
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

Review 5.  Immune cells as anti-cancer therapeutic targets and tools.

Authors:  Magnus Johansson; Tingting Tan; Karin E de Visser; Lisa M Coussens
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

6.  T-lymphocytic infiltrate in canine mammary tumours: clinic and prognostic implications.

Authors:  Maria Isabel Carvalho; Isabel Pires; Justina Prada; Felisbina L Queiroga
Journal:  In Vivo       Date:  2011 Nov-Dec       Impact factor: 2.155

Review 7.  Immunogenic HER-2/neu peptides as tumor vaccines.

Authors:  Constantin N Baxevanis; Nectaria N Sotiriadou; Angelos D Gritzapis; Panagiota A Sotiropoulou; Sonia A Perez; Nike T Cacoullos; Michael Papamichail
Journal:  Cancer Immunol Immunother       Date:  2005-10-27       Impact factor: 6.968

8.  High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates.

Authors:  Gabriela Alexe; Gul S Dalgin; Daniel Scanfeld; Pablo Tamayo; Jill P Mesirov; Charles DeLisi; Lyndsay Harris; Nicola Barnard; Maritza Martel; Arnold J Levine; Shridar Ganesan; Gyan Bhanot
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

9.  EGFR amplification and lack of activating mutations in metaplastic breast carcinomas.

Authors:  J S Reis-Filho; C Pinheiro; M B K Lambros; F Milanezi; S Carvalho; K Savage; P T Simpson; C Jones; S Swift; A Mackay; R M Reis; J L Hornick; E M Pereira; F Baltazar; C D M Fletcher; A Ashworth; S R Lakhani; F C Schmitt
Journal:  J Pathol       Date:  2006-08       Impact factor: 7.996

Review 10.  Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression.

Authors:  David G DeNardo; Lisa M Coussens
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  5 in total

Review 1.  A role for T-lymphocytes in human breast cancer and in canine mammary tumors.

Authors:  Maria Isabel Carvalho; Isabel Pires; Justina Prada; Felisbina L Queiroga
Journal:  Biomed Res Int       Date:  2014-02-02       Impact factor: 3.411

Review 2.  Know Thy Model: Charting Molecular Homology in Stromal Reprogramming Between Canine and Human Mammary Tumors.

Authors:  Enni Markkanen
Journal:  Front Cell Dev Biol       Date:  2019-12-17

3.  Factors related to the suppression of the antitumour immune response in female dogs with inflammatory mammary carcinoma.

Authors:  Karine Araújo Damasceno; Aline Michelle Dos Santos-Conceição; Laís Pereira Silva; Thiago Marconi de Souza Cardoso; Carlos Humberto da Costa Vieira-Filho; Samantha Hellen Santos Figuerêdo; Emanoel Martins-Filho; Barbra Gabriela Oliveira de Faria; João Moreira da Costa-Neto; Geovanni Dantas Cassali; Alessandra Estrela-Lima
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.752

4.  PLK1 Is a Potential Prognostic Factor Associated with the Tumor Microenvironment in Lung Adenocarcinoma.

Authors:  Lina Wang; Man Gao; Dongjie Sun; Haitao Wu; Shuang Lv; Yulin Li; Lisha Li
Journal:  Biomed Res Int       Date:  2022-07-30       Impact factor: 3.246

5.  The Expression of Selected Factors Related to T Lymphocyte Activity in Canine Mammary Tumors.

Authors:  Joanna K Bujak; Iwona M Szopa; Rafał Pingwara; Olga Kruczyk; Natalia Krzemińska; Joanna Mucha; Kinga Majchrzak-Kuligowska
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.